Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Follow-Up Questions
Who is the CEO of Artivion Inc?
Mr. James Mackin is the Chairman of the Board of Artivion Inc, joining the firm since 2014.
What is the price performance of AORT stock?
The current price of AORT is $40.61, it has decreased 1.8% in the last trading day.
What are the primary business themes or industries for Artivion Inc?
Artivion Inc belongs to Health Care industry and the sector is Health Care
What is Artivion Inc market cap?
Artivion Inc's current market cap is $1.9B
Is Artivion Inc a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for Artivion Inc, including 4 strong buy, 7 buy, 2 hold, 0 sell, and 4 strong sell